RENAL INSUFFICIENCY, CHRONIC
Clinical trials for RENAL INSUFFICIENCY, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new RENAL INSUFFICIENCY, CHRONIC trials appear
Sign up with your email to follow new studies for RENAL INSUFFICIENCY, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can text messages and game points tame high blood pressure?
Disease control CompletedThis pilot study tested a program called SMART-HABITS-4-Health to see if it could help people with chronic kidney disease, diabetes, and high blood pressure manage their condition better. 70 participants used a smartphone app to track their blood pressure and received daily text …
Matched conditions: RENAL INSUFFICIENCY, CHRONIC
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
First human test for kidney disease drug begins
Disease control CompletedThis early-stage study tested the safety and side effects of a single dose of an experimental drug called Gemini in 40 adults with moderate to severe chronic kidney disease. Researchers compared Gemini to a placebo (inactive substance) to see how well it was tolerated and how the…
Matched conditions: RENAL INSUFFICIENCY, CHRONIC
Phase: PHASE1, PHASE2 • Sponsor: Revelation Biosciences, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Phone app aims to help kidney patients stay on track
Disease control CompletedThis small pilot study tested whether a smartphone app could help people with chronic kidney disease and high blood pressure better manage their health. The app sent reminders to check blood pressure and walk more, and provided feedback and educational resources. Researchers want…
Matched conditions: RENAL INSUFFICIENCY, CHRONIC
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug trial aims to keep kidney patients' potassium in check
Disease control CompletedThis study tested a medication called patiromer in Chinese adults with chronic kidney disease and high potassium levels. The goal was to see if patiromer could safely and effectively lower potassium, allowing patients to continue taking their important heart and kidney medication…
Matched conditions: RENAL INSUFFICIENCY, CHRONIC
Phase: PHASE3 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for safer diabetes care in kidney patients?
Disease control CompletedThis study tested if a once-daily, extended-release version of the common diabetes drug metformin is safe and effective for controlling blood sugar in people who have both type 2 diabetes and mild-to-moderate chronic kidney disease. Researchers monitored 12 participants' glucose …
Matched conditions: RENAL INSUFFICIENCY, CHRONIC
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Heart of the matter: can a pill fix blood vessels in kidney disease?
Disease control CompletedThis study tested whether a 12-week course of the drug dapagliflozin, which is usually for diabetes, could improve blood vessel health in people with chronic kidney disease who do not have diabetes. It involved 32 patients who were randomly assigned to receive either the drug or …
Matched conditions: RENAL INSUFFICIENCY, CHRONIC
Phase: PHASE2 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Massive brazilian study screens thousands for hidden kidney disease
Knowledge-focused CompletedThis study aimed to find out how many adults in Brazil with risk factors like diabetes or high blood pressure might have undiagnosed chronic kidney disease. Researchers used a quick finger-prick test at local clinics to screen over 8,400 people across the country. People with abn…
Matched conditions: RENAL INSUFFICIENCY, CHRONIC
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC